financetom
Business
financetom
/
Business
/
Tariff Challenges Persist For Stanley Black & Decker, Company Cuts Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tariff Challenges Persist For Stanley Black & Decker, Company Cuts Outlook
Nov 4, 2025 7:55 AM

Stanley Black & Decker, Inc. ( SWK ) shares were volatile Tuesday after the company reported its third-quarter results.

The company reported net sales of $3.756 billion, up 0.1% year-over-year, as price increases (+5%) and favorable currency movements (+1%) offset lower volume (-6%).

GAAP diluted EPS was $0.34, and adjusted EPS was $1.43, inclusive of a tax rate benefit. Gross margin was 31.4% and adjusted gross margin was 31.6%.

Also Read: Xylem Raises Outlook As CEO Hails Resilient Demand And Record Profit Margins

Adjusted EPS of $1.43 beat the $1.18 estimate, while sales of $3.756 billion missed the $3.765 billion estimate.

Operating cash flow was $221.2 million, and free cash flow was $155.3 million. SG&A was 21.1% of sales; adjusted SG&A was 21.0%. EBITDA margin was 6.5%; adjusted EBITDA margin was 12.3%.

The quarter included $169.1 million of non-cash asset impairment charges tied to brand prioritization (Lenox, Troy-Bilt, Irwin) and certain minority investments.

Segment & Regional Highlights

Tools & Outdoor sales were $3.255 billion, roughly flat with the prior year as price (+5%), currency (+1%), and a product line transfer from Engineered Fastening (+1%) were offset by volume (-7%). Segment margin was 11.8% and adjusted segment margin was 12.0%.

Regional total revenue growth was North America (-2%), Europe (+6%), and Rest of World (-1%); regional organic revenue was North America (-2%), Europe (flat), and Rest of World (-1%). Management cited tariff impacts alongside pricing and supply-chain transformation efficiencies.

Engineered Fastening sales rose 3% to $500.5 million, with organic revenue up 5% on strength in automotive and aerospace, partially offset by lower industrial volume. Segment margin was 11.9% and adjusted segment margin was 12.8%.

Sequentially, versus the second quarter, segment margin expanded by 470 basis points, and adjusted segment margin expanded by 200 basis points as the automotive market improved.

Cash and cash equivalents were $268.3 million, short-term borrowings were $1.355 billion, current maturities of long-term debt were $554.8 million, and long-term debt was $4.703 billion as of Sept. 27, 2025.

“The gross margin progress achieved during the third quarter illustrates our rapid and effective response to tariffs and our commitment to achieving our long-term financial objectives,” President & CEO Christopher J. Nelson said.

CFO Patrick D. Hallinan added, “During the third quarter, we prioritized meeting the needs of our end users, while executing targeted commercial strategies and supply chain adjustments to mitigate tariffs.”

The Global Cost Reduction Program generated approximately $120 million of incremental pre-tax run-rate savings in the quarter and $1.9 billion since mid-2022, toward a $2.0 billion target, supporting a long-term adjusted gross margin goal of 35% or higher.

Outlook

For 2025, GAAP EPS guidance was lowered to $2.55–$2.70 from $3.35–$3.55, versus a $3.65 estimate.

Adjusted EPS guidance was narrowed to $4.55–$4.65 from $4.55–$4.75, versus a $4.61 estimate.

Management continues to target approximately $600 million of free cash flow for the year.

Price Action: SWK shares were trading lower by 0.63% to $66.78 premarket at last check Tuesday.

Read Next:

Britain’s BP Trims Spending For Profit Growth To Offset Lower Oil Prices

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
China has shown 'utmost sincerity' over China-EU EV tariff talks, ministry says
China has shown 'utmost sincerity' over China-EU EV tariff talks, ministry says
Jul 8, 2024
BEIJING (Reuters) - China has shown the utmost sincerity over consultations relating to a European Union investigation into electric vehicle subsidies, and a comment attributed to an EU official is grossly inconsistent with the facts, the commerce ministry said on Monday. Jorge Toledo, the EU's ambassador to China, was quoted by media as saying Beijing had only recently responded to...
Boeing in talks with US defense department on impact of guilty plea - source
Boeing in talks with US defense department on impact of guilty plea - source
Jul 8, 2024
WASHINGTON (Reuters) - Boeing is in talks with the U.S. Defense Department over how the planemaker's planned guilty plea could affect its extensive government contracts, a person briefed on the matter said. Late on Sunday, the Justice Department said in a court filing that Boeing had agreed to plead guilty to a criminal fraud conspiracy charge to resolve an investigation...
Jaguar Health Unit Secures New European, Australian Patents; Shares Rise
Jaguar Health Unit Secures New European, Australian Patents; Shares Rise
Jul 8, 2024
11:21 AM EDT, 07/08/2024 (MT Newswires) -- Jaguar Health ( JAGX ) unit Napo Pharmaceuticals said Monday it secured new patents from the European and Australian patent offices for its plant-based prescription drug crofelemer. The European patent covers methods for treating short bowel syndrome, bile acid diarrhea, and diarrhea related to small intestine resection or gallbladder removal with an inhibitor...
Mirum Pharmaceuticals Gets Marketing Approval for Livmarli in Europe
Mirum Pharmaceuticals Gets Marketing Approval for Livmarli in Europe
Jul 8, 2024
11:20 AM EDT, 07/08/2024 (MT Newswires) -- Mirum Pharmaceuticals ( MIRM ) said Monday that the European Commission has approved the marketing of its oral treatment Livmarli for progressive familial intrahepatic cholestasis, or PFIC, in patients aged 3 months or more. PFIC is a disorder that causes progressive liver disease. The approval is based on a phase 3 study, which...
Copyright 2023-2026 - www.financetom.com All Rights Reserved